DK2366395T2 - Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis - Google Patents

Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis Download PDF

Info

Publication number
DK2366395T2
DK2366395T2 DK10179223.2T DK10179223T DK2366395T2 DK 2366395 T2 DK2366395 T2 DK 2366395T2 DK 10179223 T DK10179223 T DK 10179223T DK 2366395 T2 DK2366395 T2 DK 2366395T2
Authority
DK
Denmark
Prior art keywords
estrogen
treatment
composition containing
atrophical
vaginitis
Prior art date
Application number
DK10179223.2T
Other languages
English (en)
Other versions
DK2366395T1 (da
Inventor
Ingelise Kvorning
Karen Koch
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2366395(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of DK2366395T1 publication Critical patent/DK2366395T1/da
Publication of DK2366395T2 publication Critical patent/DK2366395T2/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK10179223.2T 2000-12-15 2001-12-13 Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis DK2366395T2 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200001892 2000-12-15
DKPA200001891 2000-12-15
DKPA200001890 2000-12-15
EP01270333A EP1343508B1 (en) 2000-12-15 2001-12-13 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis

Publications (2)

Publication Number Publication Date
DK2366395T1 DK2366395T1 (da) 2019-09-23
DK2366395T2 true DK2366395T2 (da) 2020-06-15

Family

ID=27222474

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10179223.2T DK2366395T2 (da) 2000-12-15 2001-12-13 Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis
DK01270333.6T DK1343508T3 (da) 2000-12-15 2001-12-13 Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01270333.6T DK1343508T3 (da) 2000-12-15 2001-12-13 Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis

Country Status (10)

Country Link
EP (3) EP2366395A1 (da)
JP (2) JP4851057B2 (da)
AT (1) ATE532521T1 (da)
AU (1) AU2002221567A1 (da)
CY (1) CY1112542T1 (da)
DE (2) DE10179223T1 (da)
DK (2) DK2366395T2 (da)
ES (2) ES2376649T3 (da)
PT (1) PT1343508E (da)
WO (1) WO2002047692A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221567A1 (en) * 2000-12-15 2002-06-24 Novo-Nordisk A/S Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
EP3272333A1 (en) * 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3603626A1 (en) 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
WO2000074684A1 (en) * 1999-06-04 2000-12-14 The General Hospital Corporation Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
AU2002221567A1 (en) * 2000-12-15 2002-06-24 Novo-Nordisk A/S Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis

Also Published As

Publication number Publication date
EP1343508B1 (en) 2011-11-09
DK1343508T3 (da) 2012-02-27
AU2002221567A1 (en) 2002-06-24
JP2004515531A (ja) 2004-05-27
ES2725774T1 (es) 2019-09-27
CY1112542T1 (el) 2015-12-09
WO2002047692A1 (en) 2002-06-20
DE10179223T1 (de) 2019-10-24
EP2366395A1 (en) 2011-09-21
DK2366395T1 (da) 2019-09-23
EP3747443A2 (en) 2020-12-09
PT1343508E (pt) 2012-02-20
JP4851057B2 (ja) 2012-01-11
EP3747443A3 (en) 2021-03-03
JP2010189409A (ja) 2010-09-02
DE20120246U1 (de) 2002-05-29
ATE532521T1 (de) 2011-11-15
EP1343508A1 (en) 2003-09-17
ES2376649T3 (es) 2012-03-15

Similar Documents

Publication Publication Date Title
EA200201000A1 (ru) Гормон-заместительная терапия
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
WO2002094275A8 (en) Use of estrogen compounds to increase libido in women
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
NZ505514A (en) Method of manufacturing a wound dressing for the application of honey
DK1157037T3 (da) GCSF-konjugater
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
DK1353700T3 (da) Præparater af östrogencyclodextrinkomplekser
EP0971705A4 (en) MEDICINE FORMULATIONS FOR HORMONE REPLACEMENT THERAPY FOR TOPICAL APPLICATION ON THE SKIN
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
HK1054918A1 (en) Compounds and compositions for delivering active agents
CY1112542T1 (el) Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
PT1001802E (pt) Preparacao farmaceutica combinada compreendendo a hormona da paratiroide e um inibidor de reabsorcao ossea
DK1051159T3 (da) Faste farmaceutiske præparater indeholdende miltefosin til oral administration ved behandling af leishmaniasis
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
YU59400A (sh) Azabiciklični ligandi 5ht1 receptora
SG154323A1 (en) Estrogen replacement therapy
TW200518778A (en) Shampoo composition
EA200601089A1 (ru) Трансдермальная доставка гормонов без необходимости использования агентов, усиливающих проникновение
AU6538801A (en) Methods and compositions using sulodexide for the treatment of diabetic nephropathy
EA200301129A1 (ru) Ингибирование ароматазы для улучшения вспомогательной репродукции
DE60202954D1 (de) Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
AR006034A1 (es) Una composicion antitranspirante, un sistema antitranspirante que la comprende y la utilizacion de un emoliente en la preparacion de la misma
IL153010A0 (en) 3,3-dimethylcyclohexane derivatives